BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2003;260:502-508. [PMID: 12736744 DOI: 10.1007/s00405-003-0581-3] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Dasgupta S, Tripathi PK, Qin H, Bhattacharya-Chatterjee M, Valentino J, Chatterjee SK. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Oral Oncol. 2006;42:306-316. [PMID: 16321566 DOI: 10.1016/j.oraloncology.2005.08.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
2 Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, Fang FM, Huang HY, Chen CM, Liu HL, Huang CY. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 2009;28:2723-37. [PMID: 19525975 DOI: 10.1038/onc.2009.128] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
3 Molthoff CF, Klabbers BM, Berkhof J, Felten JT, van Gelder M, Windhorst AD, Slotman BJ, Lammertsma AA. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT). Mol Imaging Biol 2007;9:340-7. [PMID: 17643202 DOI: 10.1007/s11307-007-0104-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
4 Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl) 2016;94:1313-26. [PMID: 27695879 DOI: 10.1007/s00109-016-1475-3] [Cited by in Crossref: 207] [Cited by in F6Publishing: 234] [Article Influence: 41.4] [Reference Citation Analysis]
5 Liang K, Yang Y, Zha D, Yue B, Qiu J, Zhang C. Overexpression of lncRNA snaR is correlated with progression and predicts poor survival of laryngeal squamous cell carcinoma. J Cell Biochem 2018. [PMID: 30506952 DOI: 10.1002/jcb.28136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wang H, Shen L, Li X, Sun M. MicroRNAs contribute to the anticancer effect of 1'-acetoxychavicol acetate in human head and neck squamous cell carcinoma cell line HN4. Biosci Biotechnol Biochem 2013;77:2348-55. [PMID: 24317043 DOI: 10.1271/bbb.130389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
7 Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer 2007;109:1791-8. [PMID: 17380529 DOI: 10.1002/cncr.22646] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
8 Wright LN, Ryscavage A, Merlino G, Yuspa SH. Modeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer. Clin Cancer Res 2012;18:170-83. [PMID: 22068661 DOI: 10.1158/1078-0432.CCR-11-1349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Gillison ML. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 2007;29:779-92. [PMID: 17230556 DOI: 10.1002/hed.20573] [Cited by in Crossref: 181] [Cited by in F6Publishing: 155] [Article Influence: 12.9] [Reference Citation Analysis]
10 Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 2011;56:595-601. [PMID: 21753766 DOI: 10.1038/jhg.2011.66] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 8.5] [Reference Citation Analysis]
11 Guerrero-Preston R, Ogawa T, Uemura M, Shumulinsky G, Valle BL, Pirini F, Ravi R, Sidransky D, Keidar M, Trink B. Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells. Int J Mol Med 2014;34:941-6. [PMID: 25050490 DOI: 10.3892/ijmm.2014.1849] [Cited by in Crossref: 102] [Cited by in F6Publishing: 79] [Article Influence: 14.6] [Reference Citation Analysis]
12 Zhang B, Wang H, Guo Z, Zhang X. Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs. J Cell Physiol 2019;234:18781-91. [PMID: 30927266 DOI: 10.1002/jcp.28517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Cui X, Yu H, Yu T, Xiao D, Wang X. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370. Aging (Albany NY) 2021;13:9900-10. [PMID: 33882027 DOI: 10.18632/aging.202746] [Reference Citation Analysis]
14 Chang PM, Tzeng C, Chen M, Tsao C, Su W, Hwang W, Chang Y, Chang S, Yang M. Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study. Cancer Chemother Pharmacol 2011;68:1477-84. [DOI: 10.1007/s00280-011-1645-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
15 Kontić M, Čolović Z, Paladin I, Gabelica M, Barić A, Pešutić-pisac V. Association between EGFR expression and clinical outcome of laryngeal HPV squamous cell carcinoma. Acta Oto-Laryngologica 2019;139:913-7. [DOI: 10.1080/00016489.2019.1651938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Geomela PA, Kontos CK, Yiotakis I, Scorilas A. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. J Oral Pathol Med 2013;42:154-61. [PMID: 22747515 DOI: 10.1111/j.1600-0714.2012.01190.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
17 Chang PM, Chen P, Chu P, Wang L, Tai S, Tsai T, Huang J, Wang Y, Chang S, Yang M. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Cancer Chemother Pharmacol 2008;63:9-17. [DOI: 10.1007/s00280-008-0702-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lee J, Moon C. Current status of experimental therapeutics for head and neck cancer. Exp Biol Med (Maywood) 2011;236:375-89. [PMID: 21427235 DOI: 10.1258/ebm.2010.010354] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
19 Ayaz L, Görür A, Yaroğlu HY, Ozcan C, Tamer L. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2013;139:1499-506. [PMID: 23817697 DOI: 10.1007/s00432-013-1469-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
20 Hanken H, Gröbe A, Cachovan G, Smeets R, Simon R, Sauter G, Heiland M, Blessmann M. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Clin Oral Investig 2014;18:269-76. [PMID: 23494454 DOI: 10.1007/s00784-013-0967-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
21 Gauthaman A, Moorthy A. Prevalence of K-ras Codon 12 Mutations in Indian Patients with Head and Neck Cancer. Indian J Clin Biochem 2021;36:370-4. [PMID: 34220014 DOI: 10.1007/s12291-020-00882-w] [Reference Citation Analysis]
22 Descargues P, Sil AK, Karin M. IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer. EMBO J 2008;27:2639-47. [PMID: 18818691 DOI: 10.1038/emboj.2008.196] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
23 Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, Lewis JS Jr, Dunn GP, Bui JD, Sunwoo JB, Uppaluri R. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res 2012;72:365-74. [PMID: 22086849 DOI: 10.1158/0008-5472.CAN-11-1831] [Cited by in Crossref: 103] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
24 Gröbe A, Hanken H, Al-Dam A, Cachovan G, Smeets R, Krohn A, Clauditz T, Grob T, Simon R, Sauter G, Kluwe L, Heiland M, Blessmann M. P53 immunohistochemical expression does not correlate with clinical features in 207 carcinomas of the oral cavity and in the head and neck region. Clin Oral Investig 2014;18:211-7. [PMID: 23404560 DOI: 10.1007/s00784-013-0939-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Bell EB, Reis IM, Cohen ER, Almuhaimid T, Smith DH, Alotaibi F, Gordon C, Gomez-Fernandez C, Goodwin WJ, Franzmann EJ. Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels. Nutrients 2021;13:372. [PMID: 33530399 DOI: 10.3390/nu13020372] [Reference Citation Analysis]
26 Hoover AC, Strand GL, Nowicki PN, Anderson ME, Vermeer PD, Klingelhutz AJ, Bossler AD, Pottala JV, Hendriks WJ, Lee JH. Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway. Oncogene 2009;28:3960-70. [PMID: 19734941 DOI: 10.1038/onc.2009.251] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
27 Vairaktaris E, Papageorgiou G, Derka S, Moulavassili P, Nkenke E, Kessler P, Vassiliou S, Papakosta V, Spyridonidou S, Vylliotis A, Lazaris AC, Anagnostopoulou S, Mourouzis C, Yapijakis C, Patsouris E. Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis. J Cancer Res Clin Oncol 2007;133:227-33. [DOI: 10.1007/s00432-006-0161-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
28 Lin JH, Hsieh SC, Chen JN, Tsai MH, Chang CC. WWP1 gene is a potential molecular target of human oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:221-31. [PMID: 23849376 DOI: 10.1016/j.oooo.2013.05.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
29 Sakr WA, Gale N, Gnepp DR, Crissman JD. Squamous Intraepithelial Neoplasia of the Upper Aerodigestive Tract. Diagnostic Surgical Pathology of the Head and Neck. Elsevier; 2009. pp. 1-44. [DOI: 10.1016/b978-1-4160-2589-4.00001-2] [Cited by in Crossref: 9] [Article Influence: 0.8] [Reference Citation Analysis]
30 Sun S, Gong C, Yuan K. LncRNA UCA1 promotes cell proliferation, invasion and migration of laryngeal squamous cell carcinoma cells by activating Wnt/β-catenin signaling pathway. Exp Ther Med 2019;17:1182-9. [PMID: 30679991 DOI: 10.3892/etm.2018.7097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
31 Ricieri Brito JA, Gomes CC, Santos Pimenta FJ, Barbosa AA, Prado MA, Prado VF, Gomez MV, Gomez RS. Reduced expression of mir15a in the blood of patients with oral squamous cell carcinoma is associated with tumor staging. Exp Ther Med 2010;1:217-21. [PMID: 23136618 DOI: 10.3892/etm_00000035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
32 Pastorcic-Grgic M, Sarcevic B, Dosen D, Juretic A, Spagnoli GC, Grgic M. Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer. Head Neck. 2010;32:1178-1184. [PMID: 20029985 DOI: 10.1002/hed.21314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
33 Nasry WHS, Rodriguez-Lecompte JC, Martin CK. Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. Cancers (Basel) 2018;10:E348. [PMID: 30248985 DOI: 10.3390/cancers10100348] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
34 Dahiya K, Dhankhar R. Updated overview of current biomarkers in head and neck carcinoma. World J Methodol 2016; 6(1): 77-86 [PMID: 27018324 DOI: 10.5662/wjm.v6.i1.77] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
35 Jian CX, Yang MZ, Li P, Xiong J, Zhang ZJ, Li CJ, Chen A, Hu CM, Zhou JX, Li SH. Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma. Cancer Invest 2012;30:748-56. [PMID: 23088770 DOI: 10.3109/07357907.2012.734355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
36 Klobučar M, Sedić M, Gehrig P, Grossmann J, Bilić M, Kovač-Bilić L, Pavelić K, Kraljević Pavelić S. Basement membrane protein ladinin-1 and the MIF-CD44-β1 integrin signaling axis are implicated in laryngeal cancer metastasis. Biochim Biophys Acta 2016;1862:1938-54. [PMID: 27460703 DOI: 10.1016/j.bbadis.2016.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
37 Cohen ER, Reis IM, Gomez C, Pereira L, Freiser ME, Hoosien G, Franzmann EJ. Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2017;157:239-51. [PMID: 28397583 DOI: 10.1177/0194599817700371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
38 Yang M, Chang PM, Tzeng C, Chang S, Chu P, Tai S, Tsai T, Wang Y, Huang J, Wang H, Chen P. Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study. Cancer Chemother Pharmacol 2010;65:259-65. [DOI: 10.1007/s00280-009-1030-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Xu J, Lin DI. Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas. PLoS One 2018;13:e0199688. [PMID: 29969496 DOI: 10.1371/journal.pone.0199688] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
40 Sun X, Li J, Sica G, Fan SQ, Wang Y, Chen Z, Muller S, Chen ZG, Fu X, Dong XY, Guo P, Shin DM, Dong JT. Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma. Head Neck 2013;35:1007-14. [PMID: 22791392 DOI: 10.1002/hed.23077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
41 Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Shozu M, Okamoto Y, Seki N. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget. 2011;2:29-42. [PMID: 21378409 DOI: 10.18632/oncotarget.213] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 12.4] [Reference Citation Analysis]
42 Silva SD, Alaoui-Jamali MA, Hier M, Soares FA, Graner E, Kowalski LP. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clin Exp Metastasis 2014;31:307-16. [PMID: 24338375 DOI: 10.1007/s10585-013-9629-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
43 Rashad UM, Hussein MR, Algizawy SM. Alterations of p53 and Bcl-2 protein expression in the recurrent laryngeal and pharyngeal squamous cell carcinoma. American Journal of Otolaryngology 2011;32:210-4. [DOI: 10.1016/j.amjoto.2010.01.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
44 Gaykalova DA, Mambo E, Choudhary A, Houghton J, Buddavarapu K, Sanford T, Darden W, Adai A, Hadd A, Latham G, Danilova LV, Bishop J, Li RJ, Westra WH, Hennessey P, Koch WM, Ochs MF, Califano JA, Sun W. Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS One 2014;9:e93102. [PMID: 24667986 DOI: 10.1371/journal.pone.0093102] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
45 Stacy DR, Ely K, Massion PP, Yarbrough WG, Hallahan DE, Sekhar KR, Freeman ML. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck 2006;28:813-8. [DOI: 10.1002/hed.20430] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 6.8] [Reference Citation Analysis]
46 Pukkila M, Kosunen A, Ropponen K, Virtaniemi J, Kellokoski J, Kumpulainen E, Pirinen R, Nuutinen J, Johansson R, Kosma VM. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. J Clin Pathol 2007;60:267-72. [PMID: 16731595 DOI: 10.1136/jcp.2005.034181] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
47 Deshpande AM, Wong DT. Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther 2008;8:799-809. [PMID: 18471051 DOI: 10.1586/14737140.8.5.799] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
48 Vasvari GP, Dyckhoff G, Kashfi F, Lemke B, Lohr J, Helmke BM, Schirrmacher V, Plinkert PK, Beckhove P, Herold-mende CC. Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activityin vitro andin vivo. Int J Cancer 2007;121:1697-704. [DOI: 10.1002/ijc.22867] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
49 Dietz A, Wichmann G. [Translational research in head and neck cancer. Biological characteristics and general aspects]. HNO 2011;59:874-84. [PMID: 21861150 DOI: 10.1007/s00106-011-2361-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kim SH, Lee SY, Park HR, Sung JM, Park AR, Kang S, Kim BG, Choi YP, Kim YB, Cho NH. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 2011;117:1864-73. [PMID: 21509763 DOI: 10.1002/cncr.25760] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
51 Juhász A, Balázs M, Sziklay I, Rákosy Z, Treszl A, Répássy G, Ádány R. Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization. Cytometry 2005;67A:151-60. [DOI: 10.1002/cyto.a.20165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
52 Maemoto S, Yumoto M, Ibata M, Torizuka S, Ozawa N, Tatsumi S, Hashido M, Morikawa M, Maeda G, Imai K. Mutational analysis of HRAS and KRAS genes in oral carcinoma cell lines. Odontology 2012;100:149-55. [PMID: 21607592 DOI: 10.1007/s10266-011-0032-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
53 Wang F, Song G, Liu M, Li X, Tang H. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett 2011;585:3263-9. [PMID: 21924268 DOI: 10.1016/j.febslet.2011.08.052] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
54 Hassumi-Fukasawa MK, Miranda-Camargo FA, Guimarães MC, Simões RT, Donadi EA, Soares CP, Soares EG. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma. Eur Arch Otorhinolaryngol 2012;269:1795-804. [PMID: 22310835 DOI: 10.1007/s00405-012-1937-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
55 Cohen ER, Reis IM, Gomez-Fernandez C, Smith D, Pereira L, Freiser ME, Marotta G, Thomas GR, Sargi ZB, Franzmann EJ. CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients. Oral Oncol 2020;106:104720. [PMID: 32325304 DOI: 10.1016/j.oraloncology.2020.104720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
56 Hu YJ, Sun WW, Zhao TC, Liu Y, Zhu DW, Wang LZ, Li J, Zhang CP, Zhang ZY, Zhong LP. Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase-3 pathway in oral cancer. Oncol Lett 2020;20:154. [PMID: 32934722 DOI: 10.3892/ol.2020.12015] [Reference Citation Analysis]
57 Nasser W, Flechtenmacher C, Holzinger D, Hofele C, Bosch FX. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias: Biomarkers for potential malignant progression. Journal of Oral Pathology & Medicine 2011;40:629-35. [DOI: 10.1111/j.1600-0714.2011.01026.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
58 Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer. 2011;11:558-572. [PMID: 21734724 DOI: 10.1038/nrc3090] [Cited by in Crossref: 845] [Cited by in F6Publishing: 789] [Article Influence: 84.5] [Reference Citation Analysis]
59 Qie S, Diehl JA. Cyclin D degradation by E3 ligases in cancer progression and treatment. Semin Cancer Biol 2020;67:159-70. [PMID: 32006569 DOI: 10.1016/j.semcancer.2020.01.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
60 de Barros E Lima Bueno R, Ramão A, Pinheiro DG, Alves CP, Kannen V, Jungbluth AA, de Araújo LF, Muys BR, Fonseca AS, Plaça JR, Panepucci RA, Neder L, Saggioro FP, Mamede RC, Figueiredo DL, Silva WA Jr. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma. Tumour Biol 2016;37:15087-96. [PMID: 27658780 DOI: 10.1007/s13277-016-5356-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
61 Szaniszlo P, Fennewald SM, Qiu S, Kantara C, Shilagard T, Vargas G, Resto VA. Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer. Head Neck 2014;36:1638-47. [PMID: 24115017 DOI: 10.1002/hed.23500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kim S, Lee O, Choi J, Park Y, Kim Y, Yeo M, Kim J, Rha K. Pattern of Expression of Cell Cycle–related Proteins in Malignant Transformation of Sinonasal Inverted Papilloma. Am J Rhinol�Allergy 2011;25:75-81. [DOI: 10.2500/ajra.2011.25.3566] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
63 Katada K, Tomonaga T, Satoh M, Matsushita K, Tonoike Y, Kodera Y, Hanazawa T, Nomura F, Okamoto Y. Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma. Journal of Proteomics 2012;75:1803-15. [DOI: 10.1016/j.jprot.2011.12.018] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
64 Vairaktaris E, Spyridonidou S, Papakosta V, Vylliotis A, Lazaris A, Perrea D, Yapijakis C, Patsouris E. The hamster model of sequential oral oncogenesis. Oral Oncol 2008;44:315-24. [PMID: 18061531 DOI: 10.1016/j.oraloncology.2007.08.015] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
65 Marcu LG, Yeoh E. A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. J Cancer Res Clin Oncol 2009;135:1303-14. [PMID: 19641938 DOI: 10.1007/s00432-009-0648-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
66 Patsis C, Glyka V, Yiotakis I, Fragoulis EG, Scorilas A. l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer. Transl Oncol 2012;5:288-96. [PMID: 22937181 DOI: 10.1593/tlo.12223] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
67 Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15:2850-5. [PMID: 19351747 DOI: 10.1158/1078-0432.CCR-08-3131] [Cited by in Crossref: 183] [Cited by in F6Publishing: 103] [Article Influence: 15.3] [Reference Citation Analysis]
68 Jamali Z, Asl Aminabadi N, Attaran R, Pournagiazar F, Ghertasi Oskouei S, Ahmadpour F. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 2015;51:321-31. [PMID: 25677760 DOI: 10.1016/j.oraloncology.2015.01.008] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 14.7] [Reference Citation Analysis]
69 Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ, Ghaderi A. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathol Oncol Res 2011;17:7-10. [PMID: 20340055 DOI: 10.1007/s12253-010-9261-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
70 Cohen EE. Novel therapeutic targets in squamous cell carcinoma of the head and neck. Seminars in Oncology 2004;31:755-68. [DOI: 10.1053/j.seminoncol.2004.09.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
71 Verma M, Dahiya K, Soni A, Dhankhar R, Ghalaut VS, Bansal A, Kaushal V. Levels of neutrophil gelatinase-assosciated lipocalin in patients with head and neck squamous cell carcinoma in Indian population from Haryana state. World J Clin Oncol 2017; 8(3): 261-265 [PMID: 28638796 DOI: 10.5306/wjco.v8.i3.261] [Reference Citation Analysis]
72 Patsis C, Yiotakis I, Scorilas A. Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. Clin Biochem 2012;45:623-30. [PMID: 22429520 DOI: 10.1016/j.clinbiochem.2012.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
73 Kontić M, Milovanović J, Čolović Z, Poljak NK, Šundov Ž, Sučić A, Pešutić-Pisac V. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2015;272:401-5. [PMID: 25294054 DOI: 10.1007/s00405-014-3323-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
74 Gologan O, Barnes EL, Hunt JL. Potential Diagnostic Use of p16INK4A, a New Marker That Correlates With Dysplasia in Oral Squamoproliferative Lesions. American Journal of Surgical Pathology 2005;29:792-6. [DOI: 10.1097/01.pas.0000163361.40357.b8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
75 Bian K, Fan J, Zhang X, Yang X, Zhu H, Wang L, Sun J, Meng Y, Cui P, Cheng S, Zhang J, Zhao J, Yang A, Zhang R. MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Letters 2012;586:804-9. [DOI: 10.1016/j.febslet.2012.01.050] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
76 Ferrari D, Codecà C, Fiore J, Moneghini L, Bosari S, Foa P. Biomolecular markers in cancer of the tongue. J Oncol 2009;2009:412908. [PMID: 19696947 DOI: 10.1155/2009/412908] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
77 Jakovčević A, Žarković K, Jakovčević D, Rakušić Z, Prgomet D, Waeg G, Šunjić SB, Žarković N. The Appearance of 4-Hydroxy-2-Nonenal (HNE) in Squamous Cell Carcinoma of the Oropharynx. Molecules 2020;25:E868. [PMID: 32079077 DOI: 10.3390/molecules25040868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
78 Mojtahedi Z, Khademi B, Yehya A, Talebi A, Fattahi MJ, Ghaderi A. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma. J Laryngol Otol 2012;126:175-9. [PMID: 21888745 DOI: 10.1017/S0022215111002349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Xu T, Xiao D, Zhang X. ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo.. Oncol Lett 2013;5:1921-6. [PMID: 23833667 DOI: 10.3892/ol.2013.1298] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
80 Chang PM, Teng H, Chen P, Chang S, Chu P, Tsai T, Tai S, Wang Y, Huang J, Yang M. Methotrexate and Leucovorin Double-modulated 5-Fluorouracil Combined with Cisplatin (MPFL) in Metastatic/Recurrent Head and Neck Cancer. Journal of the Chinese Medical Association 2008;71:336-41. [DOI: 10.1016/s1726-4901(08)70135-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
81 García-Fernández E, De Diego JI, Collantes-Bellido E, Mendiola M, Prim MP, Pérez-Fernández E, Miguel-Martín M, Nistal M, Hardisson D. Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications. Histopathology 2011;58:368-76. [PMID: 21299608 DOI: 10.1111/j.1365-2559.2011.03757.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
82 Moon C, Chae YK, Lee J. Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab. Exp Biol Med (Maywood) 2010;235:907-20. [DOI: 10.1258/ebm.2009.009181] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
83 Xu T, Yu C, Sun J, Liu Y, Wang X, Pi L, Tian Y, Zhang X. Bone Morphogenetic Protein-4-induced Epithelial-Mesenchymal Transition and Invasiveness Through Smad1-mediated Signal Pathway in Squamous Cell Carcinoma of the Head and Neck. Archives of Medical Research 2011;42:128-37. [DOI: 10.1016/j.arcmed.2011.03.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
84 Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005;262:890-8. [PMID: 15739081 DOI: 10.1007/s00405-005-0916-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
85 Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, Shah PM, Verma RJ. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009;31:1544-56. [PMID: 19424974 DOI: 10.1002/hed.21126] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 8.0] [Reference Citation Analysis]
86 Shimizu S, Tsukada J, Sugimoto T, Kikkawa N, Sasaki K, Chazono H, Hanazawa T, Okamoto Y, Seki N. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway. Int J Cancer 2008;123:1816-23. [PMID: 18661521 DOI: 10.1002/ijc.23710] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
87 Silva SD, Cunha IW, Younes RN, Soares FA, Kowalski LP, Graner E. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas. Oral Dis 2010;16:774-80. [PMID: 20604875 DOI: 10.1111/j.1601-0825.2010.01687.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
88 Sun C, Han C, Wang P, Jin Y, Sun Y, Qu L. HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC. Biomed Res Int 2017;2017:3680305. [PMID: 28808656 DOI: 10.1155/2017/3680305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
89 Xu Y, Zhou J, Carey TE, McHugh JB, Voorhees JJ, Fisher GJ. Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma. Neoplasia 2012;14:1015-22. [PMID: 23226095 DOI: 10.1593/neo.12870] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
90 Yazdani J, Ghavimi MA, Jabbari Hagh E, Ahmadpour F. The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis. Mol Diagn Ther 2018;22:523-35. [PMID: 30006812 DOI: 10.1007/s40291-018-0351-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
91 de Sousa EA, Lourenço SV, de Moraes FP, Vartanian JG, Gonçalves-Filho J, Kowalski LP, Soares FA, Coutinho-Camillo CM. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation. Head Neck 2015;37:1410-6. [PMID: 24824527 DOI: 10.1002/hed.23765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
92 Liu Z, Zhang X, Huang D, Liu Y, Zhang X, Liu L, Li G, Dai Y, Tan H, Xiao J, Tian Y. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance. Med Oncol 2012;29:3381-8. [DOI: 10.1007/s12032-012-0306-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
93 Calli AO, Sari A, Cakalagaoglu F, Altinboga AA, Oncel S. ETS-1 proto-oncogene as a key newcomer molecule to predict invasiveness in laryngeal carcinoma. Pathol Res Pract 2011;207:628-33. [PMID: 21940109 DOI: 10.1016/j.prp.2011.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
94 Nohata N, Hanazawa T, Kinoshita T, Okamoto Y, Seki N. MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma. Auris Nasus Larynx. 2013;40:143-149. [PMID: 22831895 DOI: 10.1016/j.anl.2012.07.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
95 Maržić D, Čoklo M, Marijić B, Hadžisejdić I, Dekanić A, Krstulja M, Šepić T, Avirović M, Braut T. The expression of ribonuclear protein IMP3 in laryngeal carcinogenesis. Pathol Res Pract 2020;216:152974. [PMID: 32370989 DOI: 10.1016/j.prp.2020.152974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
96 Chang AR, Wu H, Park CI, Jun YK, Kim C. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer. Head Neck 2008;30:852-7. [DOI: 10.1002/hed.20788] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
97 Ayaz L, Görür A, Yaroğlu HY, Ozcan C, Tamer L. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2013;139:1499-1506. [PMID: 23817697 DOI: 10.1007/s00432-013-1469-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Petrova D, Jankova R, Yosifova A, Tzenova V, Dimova I, Toncheva D. Tissue microarray analysis of EGFR gene amplification and gain in Bulgarian patients with colorectal cancer. Onkologie 2006;29:198-200. [PMID: 16679780 DOI: 10.1159/000092646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
99 Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS. Detection of survivin and p53 in human oral cancer: Correlation with clinicopathologic findings. Head Neck 2009;31:1039-48. [DOI: 10.1002/hed.21071] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
100 Görögh T, Quabius ES, Meyer P, Hoffmann M. Characterisation of seven newly established head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol 2015;272:1251-8. [DOI: 10.1007/s00405-014-3073-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
101 Pavlovic B, Djukic V, Milovanovic J, Tomanovic N, Milovanovic A, Trivic A. Morphometric analysis of Ki-67 and p16 expression in laryngeal precursor lesions. Eur Arch Otorhinolaryngol 2013;270:1405-10. [PMID: 23408022 DOI: 10.1007/s00405-013-2383-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
102 Lu SL, Herrington H, Reh D, Weber S, Bornstein S, Wang D, Li AG, Tang CF, Siddiqui Y, Nord J, Andersen P, Corless CL, Wang XJ. Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev 2006;20:1331-42. [PMID: 16702406 DOI: 10.1101/gad.1413306] [Cited by in Crossref: 150] [Cited by in F6Publishing: 141] [Article Influence: 10.0] [Reference Citation Analysis]
103 Strzelczyk JK, Gołąbek K, Cuber P, Krakowczyk Ł, Owczarek AJ, Fronczek M, Choręża P, Hudziec E, Ostrowska Z. Comparison of Selected Protein Levels in Tumour and Surgical Margin in a Group of Patients with Oral Cavity Cancer. Biochem Genet 2017;55:322-34. [DOI: 10.1007/s10528-017-9799-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Scheckenbach K, Baldus SE, Balz V, Freund M, Pakropa P, Sproll C, Schäfer KL, Wagenmann M, Schipper J, Hanenberg H. RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral Oncol 2014;50:196-9. [PMID: 24315737 DOI: 10.1016/j.oraloncology.2013.11.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
105 de Carvalho CH, Nonaka CF, de Araújo CR, de Souza LB, Pinto LP. Immunoexpression of bone morphogenetic protein-2 (BMP-2), BMP receptor type IA, and BMP receptor type II in metastatic and non-metastatic lower lip squamous cell carcinoma. J Oral Pathol Med 2011;40:181-6. [PMID: 21059107 DOI: 10.1111/j.1600-0714.2010.00974.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]